117903-61-4

Basic information

• Product Name: PHENOL, 2,2''-[[1,2-BIS(4-CHLOROPHENYL)1,2-ETHANEDIYL]BIS(NITRILOMETHYLIDYNE)]BIS- R,S
• Synonyms: PHENOL, 2,2''-[[1,2-BIS(4-CHLOROPHENYL)1,2-ETHANEDIYL]BIS(NITRILOMETHYLIDYNE)]BIS- R,S
• CAS NO: 117903-61-4
• Molecular Formula: C28H22O2N2Cl2
• Molecular Weight: 489.39
• Mol File: 117903-61-4.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: PHENOL, 2,2''-[[1,2-BIS(4-CHLOROPHENYL)1,2-ETHANEDIYL]BIS(NITRILOMETHYLIDYNE)]BIS- R,S(CAS DataBase Reference)
• NIST Chemistry Reference: PHENOL, 2,2''-[[1,2-BIS(4-CHLOROPHENYL)1,2-ETHANEDIYL]BIS(NITRILOMETHYLIDYNE)]BIS- R,S(117903-61-4)
• EPA Substance Registry System: PHENOL, 2,2''-[[1,2-BIS(4-CHLOROPHENYL)1,2-ETHANEDIYL]BIS(NITRILOMETHYLIDYNE)]BIS- R,S(117903-61-4)

Safety Data

• Hazardous Substances Data: 117903-61-4(Hazardous Substances Data)

Usage

Description

PHENOL, 2,2''-[[1,2-BIS(4-CHLOROPHENYL)1,2-ETHANEDIYL]BIS(NITRILOMETHYLIDYNE)]BISR,S, also known as 2,2''-((1E,1''E)-(((1R,2S)-1,2-Bis(4-chlorophenyl)ethane-1,2-diyl)bis(azanylylidene))bis(methanylylidene))diphenol, is a complex organic compound with a unique chemical structure. It is characterized by its phenol core and the presence of chlorophenyl and ethanediyl groups, which contribute to its chemical properties and potential applications.

Uses

1. Used in Pharmaceutical Industry:
PHENOL, 2,2''-[[1,2-BIS(4-CHLOROPHENYL)1,2-ETHANEDIYL]BIS(NITRILOMETHYLIDYNE)]BISR,S is used as an intermediate in the synthesis of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes. These complexes possess significant antitumor activity, making them valuable in the development of novel cancer treatments.
2. Used in Anticancer Applications:
As an intermediate in the synthesis of dichloro(1,2-diphenylethylenediamine)platinum(II) complexes, PHENOL, 2,2''-[[1,2-BIS(4-CHLOROPHENYL)1,2-ETHANEDIYL]BIS(NITRILOMETHYLIDYNE)]BISR,S contributes to the development of new anticancer agents. These agents target various types of cancer, including solid malignancies, and have the potential to improve the efficacy of conventional chemotherapy by enhancing chemo-sensitivity and overcoming drug resistance.